Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPCORITAMAB vs OCRELIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EPCORITAMAB vs OCRELIZUMAB: Safety Overview

Metric EPCORITAMAB OCRELIZUMAB
Total FAERS Reports 2,041 56,186
Deaths Reported 430 1,406
Death Rate 21.1% 2.5%
Hospitalizations 1,652 10,364
Average Patient Age 67.5 yrs 47.2 yrs
% Female Patients 47.5% 72.5%
Manufacturer Genmab US, Inc. Genentech, Inc.
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status N/A Prescription